161 related articles for article (PubMed ID: 6467251)
1. The relationship of exogenous estrogens to cancer risk.
Brinton LA
Cancer Detect Prev; 1984; 7(3):159-71. PubMed ID: 6467251
[TBL] [Abstract][Full Text] [Related]
2. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
3. Review of epidemiologic studies of endometrial cancer and exogenous estrogen.
Cramer DW; Knapp RC
Obstet Gynecol; 1979 Oct; 54(4):521-6. PubMed ID: 492641
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
5. Review: oral contraceptives and menopausal estrogens in relation to breast neoplasia.
Brzezinski A; Schenker JG
Isr J Med Sci; 1982 Apr; 18(4):433-8. PubMed ID: 7045033
[TBL] [Abstract][Full Text] [Related]
6. Epidemiologic analysis of breast and gynecologic cancers.
Hulka BS
Prog Clin Biol Res; 1997; 396():17-29. PubMed ID: 9108587
[TBL] [Abstract][Full Text] [Related]
7. [Cancer risk under hormone therapy].
Lauritzen C
Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334
[TBL] [Abstract][Full Text] [Related]
8. [Are estrogens carcinogens?].
Emons G; Gründker C; Hanf V
Zentralbl Gynakol; 2002 Dec; 124(12):559-65. PubMed ID: 12822069
[TBL] [Abstract][Full Text] [Related]
9. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
Kaunitz AM
J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
[TBL] [Abstract][Full Text] [Related]
10. Use of HRT and the subsequent risk of cancer.
Beral V; Banks E; Reeves G; Appleby P
J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
[TBL] [Abstract][Full Text] [Related]
11. Cancer issues.
Marsden J; Sturdee D
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
[TBL] [Abstract][Full Text] [Related]
12. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
13. Role of exogenous female hormones in altering the risk of benign and malignant neoplasms in humans.
Thomas DB
Cancer Res; 1978 Nov; 38(11 Pt 2):3991-4000. PubMed ID: 212185
[TBL] [Abstract][Full Text] [Related]
14. Links between hormone replacement therapy and neoplasia.
Hulka BS
Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
[TBL] [Abstract][Full Text] [Related]
15. Exogenous estrogens and development of breast and endometrial cancer.
Vakil DV; Morgan RW; Halliday M
Cancer Detect Prev; 1983; 6(4-5):415-24. PubMed ID: 6652636
[TBL] [Abstract][Full Text] [Related]
16. Risks of oral contraceptive use in women over 35.
Stenchever MA
J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
[TBL] [Abstract][Full Text] [Related]
17. [Postmenopausal hormone replacement therapy and cancer of the female genitalia and breast].
Burger CW; Koomen I; Peters NA; van Leeuwen FE; Kenemans P
Ned Tijdschr Geneeskd; 1997 Feb; 141(8):368-72. PubMed ID: 9157296
[TBL] [Abstract][Full Text] [Related]
18. Endometriosis, in vitro fertilisation and the risk of gynaecological malignancies, including ovarian and breast cancer.
Vlahos NF; Economopoulos KP; Fotiou S
Best Pract Res Clin Obstet Gynaecol; 2010 Feb; 24(1):39-50. PubMed ID: 19733123
[TBL] [Abstract][Full Text] [Related]
19. Does HRT modify risk of gynecological cancers?
Schneider HP; Birkhauser M
Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():40-53. PubMed ID: 7581588
[TBL] [Abstract][Full Text] [Related]
20. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
Vessey MP
Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
